Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 20
1.
Cell Mol Biol (Noisy-le-grand) ; 68(6): 124-129, 2022 Jun 30.
Article En | MEDLINE | ID: mdl-36227667

This experiment was carried out to study the effects of estrogen on the proliferation and apoptosis of osteoblasts through regulating the G protein-coupled estrogen receptor (GPER)/protein kinase B (AKT) pathway. For this aim, osteoblasts were cultured in vitro and divided into control group, estrogen group and inhibitor group after passage. The osteoblasts in the control group were cultured normally, estrogen intervention was made in the estrogen group and G15 inhibitor intervention was made in the inhibitor group. After intervention for 24 h, osteoblasts were collected for detection. The positive expression of GPER and the double-positive expression of Tom20/Lamp2 were detected via immunofluorescence assay. The protein expressions of GPER, AKT and phosphorylated (p)-AKT were detected via Western blotting. The mRNA expression of GPER was detected via qPCR. Moreover, the autophagosomes were observed under a transmission electron microscope, and the apoptosis and cell proliferation were detected via terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay and cell counting kit-8 (CCK8) assay, respectively. Results of the immunofluorescence assay revealed that the positive expression of GPER in the estrogen group was higher than that in the control group and inhibitor group (p<0.05), while the double-positive expression of Tom20/Lamp2 in the estrogen group was lower than that in control group and inhibitor group (p<0.05). According to the results of Western blotting, the relative protein expression of AKT had no differences among the three groups (p>0.05), while the relative protein expressions of GPER and p-AKT in the estrogen group were higher than those in the control group and inhibitor group (p<0.05). The results of qPCR showed that the relative mRNA expression of GPER in the estrogen group was higher than that in the control group and inhibitor group (p<0.05). There were a small number of autophagosomes in osteoblasts in the control group and inhibitor group, while the number of autophagosomes in osteoblasts was smaller in the estrogen group. Besides, the estrogen group had a remarkably lower apoptosis rate of osteoblasts than the control group and inhibitor group and a remarkably higher proliferation rate than the control group and inhibitor group. Then estrogen can inhibit the mitochondrial autophagy of osteoblasts by regulating the GPER/AKT pathway, thereby inhibiting apoptosis and promoting cell proliferation.


Proto-Oncogene Proteins c-akt , Receptors, Estrogen , Apoptosis , Cell Proliferation , DNA Nucleotidylexotransferase/metabolism , DNA Nucleotidylexotransferase/pharmacology , Estrogens/pharmacology , GTP-Binding Proteins/metabolism , Osteoblasts/metabolism , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , RNA, Messenger , Receptors, Estrogen/genetics , Receptors, Estrogen/metabolism , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Signal Transduction
2.
Lipids Health Dis ; 21(1): 107, 2022 Oct 25.
Article En | MEDLINE | ID: mdl-36284323

BACKGROUND: It has been determined through extensive studies that autophagy, the Nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3 (NLRP3) inflammasome and apoptotic responses in macrophages jointly contribute to atherogenesis and its development in the presence of lipid abnormalities. Few studies have investigated in full-scale if the intervention time for lipids abnormality or NLRP3 activation have a significant effect on autophagy, NLRP3 or the apoptotic status in macrophages. METHODS: Human THP-1 monocyte-derived macrophages were established by challenging THP-1 monocytes with 80 µg/ml oxidized low-density lipoprotein (ox-LDL) for specific durations. Foam cell formation was observed by Oil Red O (ORO) staining. Western blots were employed to determine protein expression. Transmission electron microscope (TEM) and immunofluorescence microscopy were applied to observe the autophagic status of cells. Cell apoptosis was evaluated by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL). RESULTS: The cells were treated with ox-LDL for 12 h and 36 h, which were considered to represent early and advanced stages of atherogenesis for this study. The results showed that inhibition of ox-LDL phagocytosis by cytochalasin D in the early stage improved autophagic status, reduced NLRP3 activation and the apoptotic response significantly. In contrast, cytochalasin D had little effect on blocking the detrimental effect of ox-LDL at the advanced stage. Moreover, the changes in autophagy, apoptosis and NLRP3 expression after treatment with small interfering (si) RNA targeting NLRP3 in the early and advanced stages of atherogenesis were consistent with the above data. CONCLUSIONS: Interventions against lipid disorders or inflammatory reactions in the early or advanced stages of atherogenesis may have different results depending on when they are applied during the process of atherosclerotic pathogenesis. These results may help improve therapeutic strategies for atherosclerosis prevention. Furthermore, a healthy lifestyle should still be recommended as the most important and inexpensive measure to prevent atherogenesis.


Atherosclerosis , Inflammasomes , Humans , Inflammasomes/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein/genetics , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Cytochalasin D/metabolism , Cytochalasin D/pharmacology , DNA Nucleotidylexotransferase/metabolism , DNA Nucleotidylexotransferase/pharmacology , Lipoproteins, LDL/pharmacology , Lipoproteins, LDL/metabolism , Macrophages , Autophagy , Apoptosis , Atherosclerosis/genetics , Atherosclerosis/metabolism , Nucleotides/metabolism , Nucleotides/pharmacology , RNA/metabolism
3.
Int Heart J ; 63(5): 904-914, 2022.
Article En | MEDLINE | ID: mdl-36184550

Forsythiaside, one of the main bioactive components of Chinese medicine Lian Qiao, exerts antioxidant, anti-bacterial, and anti-inflammatory effects. To date, the mechanism of Forsythiaside in cardiomyocyte injury remains unclear. However, the antioxidant effects of Forsythiaside on cardiac cells are currently unknown. This study investigated the effect and mechanism of Forsythiaside on oxidative stress in H9c2 cardiomyocytes. H9c2 cells were treated with H2O2 and Forsythiaside and then transfected with small-interfering RNA against nuclear factor erythroid 2-related factor 2 (siNrf2). Cell viability, apoptosis, accumulation of reactive oxygen species (ROS), and mitochondrial membrane potential were measured using methyl thiazolyl tetrazolium (MTT), terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end-labeling (TUNEL) assay, fluorescent probe 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA), and rhodamine 123, respectively. The levels of oxidative stress-related markers were determined using their respective detection kits. Furthermore, the levels of apoptosis- and Nrf2 pathway-related molecules were determined via Western blot and quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Forsythiaside had no obvious toxicity on H9c2 cells. H2O2 suppressed the viability, and reduced the levels of mitochondrial membrane potential, B-cell lymphoma-2 (Bcl-2), glutathione peroxidase (GSH-Px) and catalase (CAT) and superoxide dismutase (SOD), while promoted apoptosis, ROS accumulation, and elevated the levels of cleaved caspase 3, BCL2-Associated X (Bax) and malondialdehyde (MDA) in H9c2 cells. Contrarily, Forsythiaside reversed the aforementioned effects. H2O2 advanced the levels of cytoplasm Nrf2, heme oxygenase-1 (HO-1), and nucleus Nrf2 in H9c2 cells, whereas Forsythiaside enhanced these effects. SiNrf2 reversed the functions of H2O2 or Forsythiaside in cell viability, MDA, SOD, GSH-Px, CAT, Nrf2, and HO-1 in H9c2 cells, whereas Forsythiaside reversed the aforementioned effects of siNrf2. In sum, Forsythiaside protected H9c2 cells from oxidative stress and apoptosis induced by H2O2 by activating the Nrf2/HO-1 pathway.


Heme Oxygenase-1 , NF-E2-Related Factor 2 , Anti-Inflammatory Agents/pharmacology , Antioxidants/metabolism , Antioxidants/pharmacology , Apoptosis , Caspase 3/metabolism , Catalase/metabolism , Catalase/pharmacology , DNA Nucleotidylexotransferase/metabolism , DNA Nucleotidylexotransferase/pharmacology , Fluorescent Dyes/metabolism , Fluorescent Dyes/pharmacology , Glutathione Peroxidase/metabolism , Glycosides , Heme Oxygenase-1/metabolism , Heme Oxygenase-1/pharmacology , Hydrogen Peroxide/metabolism , Hydrogen Peroxide/toxicity , Malondialdehyde/metabolism , Myocytes, Cardiac/metabolism , NF-E2-Related Factor 2/metabolism , Oxidative Stress , RNA/metabolism , Reactive Oxygen Species/metabolism , Rhodamine 123/metabolism , Rhodamine 123/pharmacology , Signal Transduction , Superoxide Dismutase/metabolism , bcl-2-Associated X Protein/metabolism
4.
Naunyn Schmiedebergs Arch Pharmacol ; 395(11): 1449-1462, 2022 11.
Article En | MEDLINE | ID: mdl-36050544

Morphine is a drug of choice for the treatment of severe and chronic pain, but tolerance to the antinociceptive effect limits its use. The development of tolerance to morphine has recently been associated with neuronal apoptosis. In this study, our aim was to investigate the effects of metformin on morphine-induced neuronal apoptosis and antinociceptive tolerance in diabetic rats. Three days of cumulative dosing were administered to establish morphine tolerance in rats. The antinociceptive effects of metformin (50 mg/kg) and test dose of morphine (5 mg/kg) were considered at 30-min intervals by thermal antinociceptive tests. To induce diabetic neuropathy, streptozotocin (STZ, 65 mg/kg) was injected intraperitoneally. ELISA kits were used to measure caspase-3, bax, and bcl-2 levels from dorsal root ganglion (DRG) tissue. Semi-quantitative scoring system was used to evaluate apoptotic cells with the the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) method. The findings suggest that co-administration of metformin with morphine to diabetic rats showed a significant increase in antinociceptive effect compared to morphine alone. The antinociceptive tests indicated that metformin significantly attenuated morphine antinociceptive tolerance in diabetic rats. In addition, metformin decreased the levels of apoptotic proteins caspase 3 and Bax in DRG neurons, while significantly increased the levels of antiapoptotic Bcl-2. Semi-quantitative scoring showed that metformin provided a significant reduction in apoptotic cell counts in diabetic rats. These data revealed that metformin demonstrated antiapoptotic activity in diabetic rat DRG neurons and attenuated morphine tolerance. The antiapoptotic activity of metformin probably plays a significant role in reducing morphine tolerance.


Diabetes Mellitus, Experimental , Diabetic Neuropathies , Metformin , Analgesics/pharmacology , Animals , Apoptosis , Caspase 3/metabolism , DNA Nucleotidylexotransferase/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Diabetic Neuropathies/drug therapy , Diabetic Neuropathies/prevention & control , Metformin/pharmacology , Metformin/therapeutic use , Morphine/pharmacology , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Streptozocin , bcl-2-Associated X Protein
5.
J Neuroinflammation ; 19(1): 231, 2022 Sep 21.
Article En | MEDLINE | ID: mdl-36131309

BACKGROUND: Radiation-induced brain injury (RIBI) is the most serious complication of radiotherapy in patients with head and neck tumors, which seriously affects the quality of life. Currently, there is no effective treatment for patients with RIBI, and identifying new treatment that targets the pathological mechanisms of RIBI is urgently needed. METHODS: Immunofluorescence staining, western blotting, quantitative real-time polymerase chain reaction (Q-PCR), co-culture of primary neurons and microglia, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay, enzyme-linked immunosorbent assay (ELISA), and CRISPR-Cas9-mediated gene editing techniques were employed to investigate the protective effects and underlying mechanisms of pregabalin that ameliorate microglial activation and neuronal injury in the RIBI mouse model. RESULTS: Our findings showed that pregabalin effectively repressed microglial activation, thereby reducing neuronal damage in the RIBI mouse model. Pregabalin mitigated inflammatory responses by directly inhibiting cytoplasmic translocation of high-mobility group box 1 (HMGB1), a pivotal protein released by irradiated neurons which induced subsequent activation of microglia and inflammatory cytokine expression. Knocking out neuronal HMGB1 or microglial TLR2/TLR4/RAGE by CRISPR/Cas9 technique significantly inhibited radiation-induced NF-κB activation and pro-inflammatory transition of microglia. CONCLUSIONS: Our findings indicate the protective mechanism of pregabalin in mitigating microglial activation and neuronal injury in RIBI. It also provides a therapeutic strategy by targeting HMGB1-TLR2/TLR4/RAGE signaling pathway in the microglia for the treatment of RIBI.


Brain Injuries , HMGB1 Protein , Animals , Brain Injuries/metabolism , Cytokines/metabolism , DNA Nucleotidylexotransferase/metabolism , DNA Nucleotidylexotransferase/pharmacology , HMGB1 Protein/metabolism , Mice , Microglia/metabolism , NF-kappa B/metabolism , Neurons/metabolism , Pregabalin/metabolism , Pregabalin/pharmacology , Pregabalin/therapeutic use , Quality of Life , Signal Transduction , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/metabolism
6.
Immun Inflamm Dis ; 10(10): e693, 2022 Oct.
Article En | MEDLINE | ID: mdl-36169254

INTRODUCTION: Hypertrophic scar (HS), a fibroproliferative disorder of the skin with some tumor-like properties, is closely related to dysregulated inflammation. PD-1/PD-L1 inhibitor is a promising medication for cancer therapy as its potent functions on adaptive immune response; whether it could be a candidate for HS therapy has aroused our interest. This study aimed to explore the effect and the mechanism of BMS-202, a PD-1/PD-L1 inhibitor, in HS. METHODS: Ten HS and adjacent normal skin tissues collected from HS patients were used to detect α-SMA, collagen I, and PD-L1 expression by Quantitative reverse transcription-polymerase chain reaction and western blot (WB) analysis. Fibroblasts derived from HS tissues (HFBs) were exposed to diverse concentrations of BMS-202, of which proliferation, migration, apoptosis, and collagen synthesis were evaluated by Cell Counting Kit-8, wound healing, terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End labeling, and [3 H]-proline incorporation assays, respectively. The effect of BMS-202 on α-SMA and collagen I expression, and transforming growth factor beta 1 (TGFß1)/Smad signaling in HFBs was also determined by WB and enzyme-linked immunosorbent assay. RESULTS: The expression level of PD-L1 was significantly elevated in both HS tissues and HFBs, which was positively correlated with α-SMA and collagen I expressions. BMS-202 exerted a significant suppression effect on the cell proliferation, migration, collagen synthesis, and α-SMA and collagen I expression of HFBs in a concentration-dependent way; but did not affect apoptosis. Finally, BMS-202 could reduce the phosphorylation of ERK1/2, Smad2, and Smad3, and the TGFß1 expression once its concentration reached 2.5 nM. CONCLUSION: BMS-202 effectively suppressed proliferation, migration, and extracellular matrix deposition of HFBs, potentially through the regulation of the ERK and TGFß1/Smad signaling pathways.


Cicatrix, Hypertrophic , Immune Checkpoint Inhibitors , B7-H1 Antigen/metabolism , Cicatrix, Hypertrophic/metabolism , Cicatrix, Hypertrophic/pathology , Cicatrix, Hypertrophic/therapy , Collagen Type I/metabolism , Collagen Type I/pharmacology , DNA Nucleotidylexotransferase/metabolism , DNA Nucleotidylexotransferase/pharmacology , Fibroblasts/metabolism , Fibroblasts/pathology , Fibrosis , Humans , Programmed Cell Death 1 Receptor/metabolism , Proline/metabolism , Proline/pharmacology , Signal Transduction
7.
J Oral Pathol Med ; 51(9): 801-809, 2022 Oct.
Article En | MEDLINE | ID: mdl-35996988

BACKGROUND: Radiation damage to salivary gland is inevitable in head and neck cancer patients receiving radiotherapy. Safe and effective treatments for protecting salivary glands from radiation are still unavailable. Mitochondrial damage is a critical mechanism in irradiated salivary gland; however, treatment targeting mitochondria has not received much attention. Nicotinamide is a key component of the mitochondrial metabolism. Here, we investigated the effects and underlying mechanisms of nicotinamide on protecting irradiated submandibular gland. METHODS: Submandibular gland cells and tissues were randomly divided into four groups: control, nicotinamide alone, radiation alone, and radiation with nicotinamide pretreatment. Cell viability was detected by PrestoBlue cell viability reagent. Histopathological alterations were observed with HE staining. Pilocarpine-stimulated saliva was measured from Wharton's duct. Cell apoptosis was determined by flow cytometry and terminal deoxynucleotidyl transferase dUTP nick-end labeling assay. Nicotinamide phosphoribosyl transferase was examined with immunofluorescence. The levels of nicotinamide adenine dinucleotide, mitochondrial membrane potential, and adenosine triphosphate were measured with the relevant kits. The mitochondrial ultrastructure was observed under transmission electron microscopy. RESULTS: Nicotinamide significantly mitigated radiation damage both in vitro and in vivo. Also, nicotinamide improved saliva secretion and reduced radiation-induced apoptosis in irradiated submandibular glands. Moreover, nicotinamide improved nicotinamide phosphoribosyl transferase and the levels of nicotinamide adenine dinucleotide/adenosine triphosphate and mitochondrial membrane potential, all of which were decreased by radiation in submandibular gland cells. Importantly, nicotinamide protected the mitochondrial ultrastructure from radiation. CONCLUSION: These findings demonstrate that nicotinamide alleviates radiation damage in submandibular gland by replenishing nicotinamide adenine dinucleotide and maintaining mitochondrial function and ultrastructure, suggesting that nicotinamide could be used as a prospective radioprotectant for preventing radiation sialadenitis.


Radiation Injuries , Submandibular Gland , Adenosine Triphosphate/metabolism , Adenosine Triphosphate/pharmacology , Animals , DNA Nucleotidylexotransferase/metabolism , DNA Nucleotidylexotransferase/pharmacology , Humans , Mitochondria , NAD/metabolism , NAD/pharmacology , Niacinamide/metabolism , Niacinamide/pharmacology , Niacinamide/therapeutic use , Pilocarpine/pharmacology , Prospective Studies , Radiation Injuries/metabolism , Radiation Injuries/pathology , Rats , Rats, Wistar , Submandibular Gland/metabolism
8.
Brain Res Bull ; 189: 44-56, 2022 10 15.
Article En | MEDLINE | ID: mdl-35985610

Amarogentin (AMA), a secoiridoid glycoside that is mainly derived from SwertiaandGentiana roots, has been confirmed to exhibit antioxidative, tumor-suppressive and anti-diabetic properties. This research intends to investigate the protective effect of AMA against sepsis-induced brain injury and its mechanism. NSC-34 and HT22 cells were treated with lipopolysaccharide (LPS) to induce an in-vitro sepsis model and then treated with varying concentrations (1, 5, 10 µM) of AMA. Cell proliferation and apoptosis were evaluated. The intensity of inflammation and oxidative stress were assessed by different methods. The AMPK/SIRT1/NF-κB pathway expression was determined by WB. An in-vitro sepsis model was set up with cecal ligation and puncture (CLP) in adult C57/BL6J mice, and different concentrations (25, 50, 100 mg/kg) of AMA were applied for treatment. Neurological function was evaluated using the modified neurological severity scores (mNSS), and the brain tissue damage was measured using hematoxylin-eosin (H&E) staining and Nissl staining. Tissue apoptosis was tested using terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Then, the AMPK inhibitor Compound C (CC) was administered to confirm AMA-mediated mechanism. Our finding illustrated that AMA mitigated LPS-induced neuronal damage, inflammation and oxidative stress, activated the AMPK/SIRT1 pathway and choked NF-κB phosphorylation. Furthermore, AMA improved neurological functions of sepsis mice by reliving neuroinflammation and oxidative stress. Inhibition of AMPK attenuated the protective effect of AMA on neurons or the mice's brain tissues. In conclusion, AMA protected against sepsis-induced brain injury by modulating the AMPK/SIRT1/NF-κB pathway.


Brain Injuries , Sepsis , AMP-Activated Protein Kinases/metabolism , Animals , Brain Injuries/drug therapy , DNA Nucleotidylexotransferase/metabolism , DNA Nucleotidylexotransferase/pharmacology , Eosine Yellowish-(YS)/pharmacology , Hematoxylin/pharmacology , Inflammation/drug therapy , Iridoid Glycosides/pharmacology , Iridoids , Lipopolysaccharides/pharmacology , Mice , NF-kappa B/metabolism , Sepsis/complications , Sepsis/drug therapy , Signal Transduction , Sirtuin 1/metabolism
9.
Brain Res Bull ; 189: 139-150, 2022 10 15.
Article En | MEDLINE | ID: mdl-35985609

BACKGROUND AND RESEARCH QUESTION/HYPOTHESIS: Excessive oligodendrocyte precursor cell (OPC) apoptosis occurs during intrauterine infection-induced white matter injury (WMI) in premature infants, preventing excessive apoptosis of OPCs is one of the mechanisms protecting WMI. Micro-RNA-21-5p (miR-21-5p) mediating anti-apoptotic activity was observed in other diseases. Therefore, the aim of this study was to determine whether miR-21-5p protects against WMI by modulating phosphatase and tensin homologue deleted on chromosome 10/phosphatidylinositol-3-kinase/protein kinase B (PTEN/PI3K/Akt) signalling pathway. METHODS: A lipopolysaccharide (LPS)-induced neonatal Sprague-Dawley (SD) rat model of preterm WMI was established. To explore the effect of miR-21-5p on WMI, we intraventricularly injected miR-21-5p agomir and miR-21-5p antagomir to activate or inhibit endogenous miR-21-5p. Immunofluorescent labelling of myelin basic protein, immunohistochemical labelling of 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNPase), and terminal deoxynucleotidyl transferase dUTP nick end labelling assays were conducted to observe pathological white matter changes. The antibody of anti-oligodendrocyte marker 4 (O4) was used to specifically recognise OPCs. The expressions of miR-21-5p and PTEN mRNA in the brain were detected with quantitative real-time polymerase chain reaction (qRT-PCR). PTEN, Akt, and phosphorylated Akt (p-Akt) protein levels were assayed with western blotting, and apoptotic proteins associated with PI3K/Akt signalling were quantified. RESULTS: Intense white matter dysplasia and excessive OPC apoptosis were observed in the brains of rats with WMI. When the miR-21-5p agonist miR-21-5p agomir was used in the WMI group, apoptosis of OPCs was significantly reduced, and myelin maturation increased. MiR-21-5p agomir relieved WMI. MiR-21-5p agomir inhibited the mRNA and protein expression of PTEN, increased p-Akt phosphorylation, and decreased the expression and activation of related apoptotic proteins.On the other hand, the administration of miR-21-5p specific blocker, miR-21-5p antagomir, reduced the level of p-AKT, increased OPC apoptosis, and worsened WMI. INTERPRETATION: Our findings revealed that miR-21-5p agomir had anti-OPC over-apoptotic effects and enhanced myelin development in WMI by modulating the PTEN/Akt signalling pathway.


MicroRNAs , Oligodendrocyte Precursor Cells , White Matter , 2',3'-Cyclic-Nucleotide Phosphodiesterases/metabolism , 2',3'-Cyclic-Nucleotide Phosphodiesterases/pharmacology , Animals , Animals, Newborn , Antagomirs/pharmacology , Apoptosis , DNA Nucleotidylexotransferase/metabolism , DNA Nucleotidylexotransferase/pharmacology , Lipopolysaccharides/pharmacology , MicroRNAs/metabolism , Myelin Basic Protein/metabolism , Myelin Basic Protein/pharmacology , Oligodendrocyte Precursor Cells/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Phosphatidylinositols/pharmacology , Phosphoric Diester Hydrolases/metabolism , Phosphoric Diester Hydrolases/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , RNA, Messenger , Rats , Rats, Sprague-Dawley , Tensins/metabolism , White Matter/metabolism
10.
Reprod Domest Anim ; 57(10): 1255-1266, 2022 Oct.
Article En | MEDLINE | ID: mdl-35780288

Oroxin A (OA) is a flavonoid isolated from Oroxylum indicum (L.) Kurz that has various biological activities, including antioxidant activities. This study aimed to examine the viability of using OA in an in vitro culture (IVC) medium for its antioxidant effects and related molecular mechanisms on porcine blastocyst development. In this study, we investigated the effects of OA on early porcine embryo development via terminal deoxynucleotidyl transferase dUTP nick-end labeling, 5-ethynyl-2'-deoxyuridine labeling, quantitative reverse transcription PCR, and immunocytochemistry. Embryos cultured in the IVC medium supplemented with 2.5 µM of OA had an increased blastocyst formation rate, total cell number, and proliferation capacity, along with a low apoptosis rate. OA supplementation decreased reactive oxygen species levels while increasing glutathione levels. OA-treated embryos exhibited an improved intracellular mitochondrial membrane potential and reduced autophagy. Moreover, levels of pluripotency- and antioxidant-related genes were upregulated, whereas those of apoptosis- and autophagy-related genes were downregulated by OA addition. In conclusion, OA improves preimplantation embryonic development by reducing oxidative stress and enhancing mitochondrial function.


Embryo Culture Techniques , Flavones , Animals , Antioxidants/metabolism , Antioxidants/pharmacology , Apoptosis , Autophagy , Blastocyst , DNA Nucleotidylexotransferase/metabolism , DNA Nucleotidylexotransferase/pharmacology , Embryo Culture Techniques/veterinary , Embryonic Development , Flavones/metabolism , Flavones/pharmacology , Glucosides , Glutathione/metabolism , Oxidative Stress , Reactive Oxygen Species/metabolism , Swine
11.
Metab Brain Dis ; 37(7): 2457-2466, 2022 10.
Article En | MEDLINE | ID: mdl-35838869

Sevoflurane, a commonly used anesthetic, has been found to cause neural stem cell (NSC) injury, thereby contributing to neurocognitive impairment following general anesthesia. Tetramethylpyrazine (TMP), one of the most widely used medicinal compounds isolated from a traditional Chinese herb, possess neuroprotective activity. However, its effect on sevoflurane-induced NSC injury remains unclear. NSCs were pretreated with indicated concentrations of TMP for 2 h and then exposed to sevoflurane for 6 h. Cell injury was measured using lactate dehydrogenase (LDH) release assay. Cell viability and proliferation were detected by cell counting kit-8 (CCK-8) assay and 5-bromo-2'-deoxyuridine (BrdU) labeling, respectively. Apoptotic cells were detected using terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. The levels of cleaved caspase-3, phosphorylated protein kinase B (Akt) and phosphorylated glycogen synthase kinase-3ß (GSK-3ß) were detected by western blotting. Our results showed exposure to sevoflurane decreased the viability and proliferation of NSCs, while TMP preserved NSC viability and proliferation after sevoflurane exposure. In addition, the expression of cleaved caspase-3 and TUNEL positive cells were markedly decreased in TMP-treated NSCs compared with the control. Furthermore, pretreatment with TMP significantly increased the levels of phosphorylated Akt and GSK-3ß in sevoflurane-injured NSCs. However, an upstream inhibitor of Akt, LY294002 abolished the protective of TMP on the cell viability of NSCs. In conclusion, these findings indicate that TMP protects NSCs from sevoflurane-induced toxicity through Akt/GSK-3ß pathway.


Neural Stem Cells , Proto-Oncogene Proteins c-akt , Rats , Animals , Proto-Oncogene Proteins c-akt/metabolism , Sevoflurane/metabolism , Sevoflurane/pharmacology , Glycogen Synthase Kinase 3 beta/metabolism , Caspase 3/metabolism , Bromodeoxyuridine/metabolism , Bromodeoxyuridine/pharmacology , DNA Nucleotidylexotransferase/metabolism , DNA Nucleotidylexotransferase/pharmacology , Signal Transduction , Rats, Sprague-Dawley , Neural Stem Cells/metabolism , Lactate Dehydrogenases/metabolism , Apoptosis
12.
J Appl Toxicol ; 42(11): 1787-1806, 2022 11.
Article En | MEDLINE | ID: mdl-35698815

One of many noteworthy consequences of increasing societal reliance on pesticides is their predominance in aquatic environments. These pernicious chemicals interact with high temperatures from global climate change, heat waves, and natural variations to create unstable environments that negatively impact organisms' health. To understand these conditions, we examined the dose-dependent effects of environmentally relevant pesticide mixtures (metolachlor, linuron, isoproturon, tebuconazole, aclonifen, atrazine, pendimethalin, and azinphos-methyl) combined with elevated temperatures (22 control vs. 32°C for 4-week exposure) on renin, dinitrophenyl protein (DNP, an indicator of reactive oxygen species, ROS), 3-nitrotyrosine protein (NTP, an indicator of reactive nitrogen species, RNS), superoxidase dismutase (SOD, an antioxidant), and catalase (CAT, an antioxidant) expressions in the kidneys of goldfish (Carassius auratus). Histopathological analysis showed widespread damage to kidney tissues in high temperature and pesticide co-exposure groups, including rupture of the epithelial layer, hemorrhaging, and degeneration of tubular epithelium. Quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemical analyses demonstrated significant declines in renin receptor-like mRNA and protein expressions in kidney tissues under combined exposure to high temperature and pesticides compared with controls; conversely, expression of DNP, NTP, SOD, and CAT increased in kidney tissues under the same conditions. Apoptotic cells were also increased in co-exposure groups as assessed by in situ terminal deoxynucleotidyl transferase dUTP nick labeling (TUNEL) assay. The enhanced apoptosis in kidneys of heat and pesticides co-exposed fish was associated with increased caspase-3 (a protease enzyme) mRNA levels. Our results demonstrated that high temperature and pesticides induced oxidative/nitrative stress (i.e., ROS/RNS), damaged tissues, increased cellular apoptosis, and suppressed renin expression in kidneys of goldfish.


Atrazine , Pesticides , Animals , Antioxidants/metabolism , Apoptosis , Atrazine/metabolism , Atrazine/pharmacology , Azinphosmethyl/metabolism , Azinphosmethyl/pharmacology , Caspase 3/metabolism , Catalase/metabolism , DNA Nucleotidylexotransferase/metabolism , DNA Nucleotidylexotransferase/pharmacology , Goldfish/metabolism , Hot Temperature , Kidney , Linuron/metabolism , Linuron/pharmacology , Oxidative Stress , Pesticides/toxicity , RNA, Messenger/metabolism , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/metabolism , Renin/metabolism , Renin/pharmacology , Superoxide Dismutase/metabolism , Temperature
13.
World Neurosurg ; 165: e1-e11, 2022 09.
Article En | MEDLINE | ID: mdl-33957285

BACKGROUND: Mesenchymal stem cells (MSCs) have been shown to enhance neurological recovery after stroke. A rat middle cerebral artery occlusion model was designed to assess neuroprotective effects of stroke pretreated MSCs on cerebral ischemia/reperfusion injury. METHODS: MSCs were isolated and cultured in medium with 10% fetal bovine serum, normal control serum, or stroke serum (SS). MSCs were then injected into rats (n = 6 in each group) 1 day after middle cerebral artery occlusion, and feeding continued for 28 days. A battery of behavioral tests, 2,3,5-triphenyltetrazolium chloride staining, hematoxylin-eosin staining, enzyme-linked immunosorbent assay, and terminal deoxynucleotidyl transferase dUTP nick end labeling assay were used to assess neural injury. To detect enhancement of neuronal regeneration and angiogenesis, immunofluorescence and Western blotting were performed to assess expression of trophic factors and growth factors. RESULTS: After treatment, behavior of rats improved significantly. Infarction area, brain lesion, and apoptosis cells were significantly decreased in the SS-MSCs group compared with the other groups. SS-MSCs also modulated inflammation by attenuating inflammatory cytokines. Furthermore, the number of neurogenesis-positive cells and expression of trophic factors and growth factors were significantly higher in the SS-MSCs group compared with the others. MSCs cultured with fetal bovine serum and normal control serum showed differences in expression of trophic factors and growth factors, but the results were not as good as with SS-MSCs. CONCLUSIONS: Administration of SS-MCSs after reperfusion led to neuroprotection by inducing the recovery process, including improving pathological changes, behavioral improvement, neurogenesis, suppression of apoptosis and inflammation, and angiogenesis.


Brain Ischemia , Mesenchymal Stem Cells , Neuroprotective Agents , Reperfusion Injury , Stroke , Animals , Apoptosis , Brain Ischemia/therapy , Cytokines/metabolism , DNA Nucleotidylexotransferase/metabolism , DNA Nucleotidylexotransferase/pharmacology , Disease Models, Animal , Eosine Yellowish-(YS)/metabolism , Eosine Yellowish-(YS)/pharmacology , Hematoxylin/metabolism , Hematoxylin/pharmacology , Infarction, Middle Cerebral Artery/therapy , Inflammation/metabolism , Neuroprotective Agents/metabolism , Neuroprotective Agents/pharmacology , Rats , Rats, Sprague-Dawley , Reperfusion Injury/metabolism , Reperfusion Injury/prevention & control , Serum Albumin, Bovine/metabolism , Serum Albumin, Bovine/pharmacology , Stroke/metabolism , Stroke/therapy
14.
Neurobiol Aging ; 32(3): 443-58, 2011 Mar.
Article En | MEDLINE | ID: mdl-19368990

Activated microglia are instrumental to neurodegeneration in Parkinson's disease (PD). Fractalkine, as an exclusive ligand for CX3CR1 expressed on microglia, has recently been reported to be released out by neurons, and induce microglial activation as a neuron-to-glia signal in the spinal cord. However, the role of fractalkine-induced microglial activation in PD remains unknown. In our study, we injected 1-methyl-4-phenylpyridinium (MPP(+)) into unilateral substantia nigra (SN) which induced ipsilateral endogenous fractalkine expression on neuron and observe the increase of CX3CR1 expression in response to MPP(+) by Western blotting analysis. Moreover, pre-administration of anti-CX3CR1 neutralizing antibody which potentially blocked microglial activation can promote rotation behaviors. To further investigate the role of fractalkine in PD, we injected exogenous fractalkine in unilateral SN, and observed microglial activation, dopaminergic cell depletion, and motor dysfunction. All these effects can be totally abolished by cerebroventricular administration of anti-CX3CR1. Intracerebroventricular administration of minocycline, a selective microglia inhibitor, can prevent fractalkine-induced rotation behaviors, and inhibit dopaminergic neurons from degeneration in the way of dose-dependent. Our studies demonstrate that fractalkine-induced microglial activation plays an important role in the development of PD, and provide an evidence of fractalkine and CX3CR1 as new therapeutic targets for PD treatment.


Chemokine CX3CL1/metabolism , Gene Expression Regulation/physiology , Mental Disorders/etiology , Parkinson Disease/complications , Parkinson Disease/pathology , Substantia Nigra/metabolism , 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/adverse effects , Analysis of Variance , Animals , Antibodies/pharmacology , Antiparkinson Agents/pharmacology , Apomorphine/pharmacology , Chemokine CX3CL1/adverse effects , Chemokine CX3CL1/immunology , DNA Nucleotidylexotransferase/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Interactions , Gene Expression Regulation/drug effects , Levodopa/pharmacology , Male , Nerve Tissue Proteins/metabolism , Parkinson Disease/drug therapy , Parkinson Disease/etiology , Rats , Rats, Sprague-Dawley , Reaction Time/drug effects , Stereotyped Behavior/drug effects , Substantia Nigra/pathology , Tyrosine 3-Monooxygenase/metabolism
15.
Methods Mol Med ; 111: 43-54, 2005.
Article En | MEDLINE | ID: mdl-15911970

Chemotherapy induces injury to tumor cells, which subsequently die by a number of processes. One of those processes is apoptosis, and its measurement can be a useful tool to understanding the mechanisms of action of chemotherapy agents, drug resistance, and tumor biology. Cells undergoing apoptosis eventually cleave their DNA with nucleases in a characteristic pattern that leaves free 3'OH ends. This permits the identification of cells undergoing apoptosis by transfer of fluorescence-labeled dUTP to the free 3'OH ends using the enzyme terminal deoxynucleotidyl transferase (TdT) in a process termed terminal deoxynucleotidyl transferase dUTP-mediated nick end labeling (TUNEL). This chapter outlines the concepts governing the measurement of apoptosis following chemotherapy by TUNEL in cells in culture and in tissue biopsied from patients or laboratory animals that received chemotherapy. It lists the reagents, procedures for cell and tissue handling, labeling techniques, caveats, and appropriate controls for labeling 3'OH termini with TdT and quantifying the results.


Antineoplastic Agents/pharmacology , Apoptosis , Cytological Techniques , In Situ Nick-End Labeling/methods , Neoplasms/pathology , Cell Adhesion , DNA/metabolism , DNA Nucleotidylexotransferase/pharmacology , Endopeptidase K/pharmacology , Flow Cytometry , Humans , Microscopy, Fluorescence , Neoplasms/drug therapy , Paraffin/chemistry
16.
Biotechniques ; 28(3): 486-90, 2000 Mar.
Article En | MEDLINE | ID: mdl-10723561

An oligonucleotide probe tailed with deoxyadenosine-5'-triphosphate or deoxythymine-5'-triphosphate is detectable with high sensitivity, but has a major drawback--the tail co-hybridizes specifically to complementary sequences. This can be a problem when screening cDNA clones that contain poly(dA) sequences. While it is possible to mask the cDNA tail with unlabeled poly(dA) or poly(A) oligonucleotides, false-positive clones are still produced because complete masking of extremely long (dA) tails is difficult. As a result, only cDNA clones that have extremely long poly(dA) sequences are often obtained by hybridization screening using tailed probes. In this report, we describe an oligonucleotide probe tailed with DIG-labeled nucleotide in combination with deoxyinosine-5'-triphosphate that was highly specific and sensitive to cDNAs. Terminal deoxynucleotidyl transferase efficiently adds dI nucleotides to the 3'-end. The dI of the tails did not pair with any nucleotides under stringent hybridization so that the specificity of hybridization assays remained high without affecting the sensitivity of the test. Colony hybridization experiments demonstrated that there were very few (1 of 80 tested) false positives using this technique. Its use may increase the accuracy of cDNA screening.


DNA Nucleotidylexotransferase/pharmacology , Oligonucleotide Probes , Deoxyadenine Nucleotides , Nucleic Acid Hybridization , Sensitivity and Specificity
17.
J Invest Dermatol ; 110(1): 24-8, 1998 Jan.
Article En | MEDLINE | ID: mdl-9424082

Sunburn cells are thought to represent ultraviolet B-induced apoptotic keratinocytes. It has been demonstrated that enzymatic and nonenzymatic antioxidants effectively suppress sunburn cell formation, indicating that reactive oxygen species may play a role in the progression of ultraviolet B-induced apoptosis. Metallothionein, a cytosol protein, has antioxidant activity, and overexpression of metallothionein has been reported to reduce the number of sunburn cells in mouse skin. We have also demonstrated that overexpression of metallothionein inhibits ultraviolet B-induced DNA ladder formation in mouse keratinocytes. These findings support the hypothesis that cellular metallothionein may play an important role in the inhibition of ultraviolet B-induced apoptosis in keratinocytes through its antioxidant activity. In the present study, we investigated the effects of beta-thujaplicin, an extract from the woods of Thuja plicata D. Don. and Chamaecyparis obtuse, Sieb. et Zucc., on ultraviolet B-induced apoptosis in keratinocytes and on metallothionein induction. Topical application of beta-thujaplicin decreased the number of ultraviolet B-mediated sunburn cells and terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling-positive cells in mouse ear skin. Incubation with beta-thujaplicin suppressed ultraviolet B-induced DNA ladder formation in cultured mouse keratinocytes. Histochemical analysis showed that topical application of beta-thujaplicin induced metallothionein protein in mouse skin. Northern analysis and western blotting revealed significant induction of metallothionein mRNA and metallothionein protein, respectively, in beta-thujaplicin-treated cultured mouse keratinocytes. These findings indicate that beta-thujaplicin inhibits ultraviolet B-induced apoptosis in keratinocytes and strongly suggest that the inhibitory mechanism is due to the antioxidant activity of metallothionein induced by the agent.


Anti-Infective Agents/pharmacology , Apoptosis/drug effects , Apoptosis/radiation effects , Keratinocytes/physiology , Monoterpenes , Tropolone/analogs & derivatives , Ultraviolet Rays , Animals , Biotin/metabolism , Cadmium/pharmacology , Cell Survival/drug effects , Cells, Cultured , DNA Fragmentation/drug effects , DNA Nucleotidylexotransferase/pharmacology , Female , Keratinocytes/cytology , Metallothionein/biosynthesis , Metallothionein/drug effects , Metallothionein/genetics , Mice , Mice, Inbred BALB C , RNA, Messenger/metabolism , Sunburn/pathology , Tropolone/pharmacology
18.
Cell Prolif ; 29(10): 539-47, 1996 Oct.
Article En | MEDLINE | ID: mdl-9051117

In this report we describe the successful application of a novel microscope-based multiparameter laser scanning cytometer (LSC) to measure duration of different phases of cell cycle in HL-60 human leukaemic cell lines by the fraction of labelled mitoses (FLM) method. Exponentially growing cells were harvested after various time intervals following pulse-labelling with 5'-bromo-2'-deoxyuridine (BrdUrd), cytocentrifuged, fixed in ethanol, and then exposed to UV light to induce DNA strand breaks at the sites of incorporated BrdUrd. The 3' OH termini of the photolytically generated DNA strand breaks were labelled with BrdUTP in the reaction catalysed by exogenous terminal deoxynucleotidyl transferase (TdT), followed by FITC-labelled BrdUrd antibodies. DNA was counterstained with propidium iodide (PI). Due to differences in chromatin structure between the interphase and mitotic cells, the LSC identified the latter by virtue of their higher red (PI) fluorescence intensity values among all pixels over the measured cell. To confirm that the cells selected were indeed cells in mitosis, predominantly in metaphase, the recorded X-Y coordinates of selected cells were used to re-position the cell for their visual examination. From the time lapse analysis of percentage BrdUrd-labelled cells progressing through mitosis it was possible to calculate the duration of individual phases of the cell cycle. The duration of S (Ts) and G2 + M (TG2 + M) was 8 and 3 h, respectively, and the minimal duration of G2 (TG2) was 2 h. The cell cycle time (Tc) estimated for the cohort of the most rapidly progressing cells was 13 h. The ability to automatically and rapidly discriminate mitotic cells combined with the possibility of their subsequent identification by image analysis makes LSC the instrument of choice for the FLM analysis.


Flow Cytometry/methods , Mitosis/drug effects , Mitosis/physiology , Time Factors , Bromodeoxyuridine/immunology , Bromodeoxyuridine/pharmacology , Cell Count , Chromatin/chemistry , DNA Fragmentation/drug effects , DNA Fragmentation/radiation effects , DNA Nucleotidylexotransferase/pharmacology , G2 Phase/drug effects , G2 Phase/physiology , Humans , Interphase/drug effects , Interphase/physiology , Metaphase/drug effects , Metaphase/physiology , Propidium/pharmacology , Tumor Cells, Cultured
19.
Anal Biochem ; 224(1): 446-9, 1995 Jan 01.
Article En | MEDLINE | ID: mdl-7535988

Terminal deoxynucleotidyltransferase is well known for its ability to add nucleotides to the 3'-ends of DNA; here we demonstrate a corresponding activity with RNA as acceptor molecule. Using DIG- or biotin-dUTP as substrate, a tailing reaction is used for nonradioactive 3'-end-labeling of RNA oligonucleotides, isolated RNA molecules such as tRNA from E. coli, and MS2 RNA as well as in vitro transcripts. The tail length and associated sensitivity of detection can be varied using DIG-ddUTP, DIG-dUTP, or a nucleotide mixture of DIG-dUTP and dATP.


DNA Nucleotidylexotransferase/pharmacology , RNA/metabolism , Base Sequence , Digoxigenin/pharmacology , Molecular Sequence Data
20.
Tsitologiia ; 25(10): 1212-5, 1983 Oct.
Article Ru | MEDLINE | ID: mdl-6659065

3H-thymidine incorporation was measured in DNA of the human lymphocytes from the peripheral blood after its PHA-stimulation in vitro. The increased PHA-stimulation was established after addition to the medium of exogenous terminal deoxynucleotidyl transferase (TDT) for cultures with small level of PHA-stimulation only. TDT without PHA exerted no stimulating action on the culture of lymphocytes.


DNA Nucleotidylexotransferase/pharmacology , DNA Nucleotidyltransferases/pharmacology , DNA/biosynthesis , Lymphocytes/drug effects , Phytohemagglutinins/pharmacology , Cells, Cultured , Humans , Lymphocytes/metabolism , Stimulation, Chemical , Thymidine/metabolism , Tritium
...